NewsRoom Articles - Page 1267 of 1450

TuesdayAug 01, 2017 1:46 pm

ChineseInvestors.com, Inc. (CIIX) Getting Some Skin in the Game

Entering $30+ billion Chinese skin care market First and only CBD-based products to market Expects to capture huge share of new skin care products category Any dispute over the efficacy of medical cannabis is settled science. Recent prestigious clinical studies have provided conclusive evidence that medical cannabinoids are effective medicine for a variety of diseases and ailments (http://nnw.fm/QWn8r). Cannabidiol (CBD) has been scientifically shown to be effective in the treatment of certain epilepsies, pain, inflammation and nausea, as well as providing relief from hangover, anxiety and stress. It comes as little surprise then that cannabis may well possess skin healing…

TuesdayAug 01, 2017 1:07 pm

Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) Sees New Round of Investors Attracted to Cannabis Market

Has patents in the United States and Australia and patents pending in more than 40 countries for proprietary technology easing how edible cannabinoids enter body Revenue stream comes from own products and 5-10% margin of gross sales from licensing technology to third parties Signed C$250,000 joint venture agreement with National Research Council (NRC) in Canada to research and find best methods for processing active agents in foods Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) already owns international patents for its proprietary intellectual property and has more global patents pending in the cannabis marketplace. It believes that the sub-sector of bioscience…

TuesdayAug 01, 2017 9:47 am

Moxian, Inc. (NASDAQ: MOXC) Offers Investors Access to Growth of World’s Largest Economy

China is now the world’s largest economy and on the brink of incredible growth Moxian is targeting owners of 75 million small- and medium-sized businesses in China with O2O tools to engage and convert online viewers to brick and mortar purchasers Social gaming, loyalty rewards and messaging allow Moxian to mine consumer data for clients' benefit while driving revenue Moxian, Inc. (NASDAQ: MOXC) is offering investors a unique opportunity to benefit from the growth of what is now the world’s largest economy. Moxian, a digital marketing company based in Shenzhen, China, is on the leading edge of e-commerce in China’s…

MondayJul 31, 2017 3:47 pm

Net Element, Inc. (NASDAQ: NETE) Lets Merchants Accept Both Online and Offline Payments

Cashless payments continue growing Technology to handle debit and credit card payments Aptito restaurant management solution driving sales The payment system has come a long way from the time when transactions were mainly settled in specie. In antiquity and during the medieval period, purses glittered with gold and silver coin. Then, paper money, used by the Chinese a thousand years before, began to appear in 17th century Europe. From the late Renaissance to the end of the 20th century, banknotes and, increasingly, checks were used to transfer funds and make payments. Now, with the internet girding the globe, these media…

MondayJul 31, 2017 2:35 pm

Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) Technology Set to Benefit as Study Shows More Benefits of Cannabidiol

Cannabidiol (CBD) combats anxiety, inflammation, nausea and vomiting Low side-effect profile means high doses of cannabidiol can be used for treatment of schizophrenia, dementia, diabetes and nausea Lower doses promote and maintain health with anti-oxidative, anti-inflammatory and neuroprotective effects Lexaria Bioscience Corp. set to benefit from increasing interest in CBD as patented technology improves taste, rapidity and effectiveness of bioactive compounds including cannabinoids A new scientific review of the safety and side effects of cannabidiol confirms and expands on the myriad known health benefits of cannabidiol and the compound’s lack of side effects. The review, titled “An Update on Safety…

MondayJul 31, 2017 9:17 am

Moleculin Biotech, Inc. (NASDAQ: MBRX) is “One to Watch”

Oncology pipeline features significant safety/efficacy advantages Lead candidate poised for FDA acceleration due to significant unmet need in AML Broad-spectrum applicability of WP1066 & WP1122 portfolios of molecules For preclinical oncology biopharma Moleculin Biotech, Inc. (NASDAQ: MBRX), the quest to deliver potentially revolutionary anti-cancer drugs to the market is enkindled by a close association with The University of Texas MD Anderson Cancer Center. This institution’s stated mission is nothing less than to make “cancer history,” and eliminate cancer on a global scale. Truly an American success story to be proud of, MD Anderson is one of the largest cancer centers…

ThursdayJul 27, 2017 3:01 pm

ProBility Media Corp.’s (PBYA) E-Learning Brand Is Transforming Businesses

July acquisition of W Marketing further expanded the ProBility educational brand into the U.S. electrical industry, a $130 billion market Products include virtual reality products for 3D animation and modeling training, thanks to a 51 percent ownership stake in ProBility Immersive Technologies ProBility Safety Academy now offers courses in private security, public safety, criminal justice and police science An EdTech company serving numerous career-intensive fields, ProBility Media Corp. (OTCQB: PBYA) is offering businesses full-service training and career advancement resources. Small- and medium-sized businesses in these areas have traditionally had to rely on disparate e-learning resources. Now, ProBility is offering high…

ThursdayJul 27, 2017 11:57 am

ChineseInvestors.com (CIIX) Takes Aim at North American, Chinese Cannabidiol Markets

CIIX’s multi-prong approach offers opportunity for investors Company to launch hemp-infused skin care product line in China Brick-and-mortar store planned for California, CBD biotech incorporated in Canada Online CBD store serves global Chinese-speaking population; Yelp style app helps Chinese-speakers find U.S. medical marijuana dispensaries ChineseInvestors.com, Inc. (OTCQB: CIIX) is offering a unique opportunity for investors as the company pursues a multi-pronged approach to conquering the rapidly expanding global markets in cannabidiol products and the medical marijuana space in Canada. The company aims to be the world’s leading publicly traded Chinese nutritional company. Globally, ChineseInvestors.com targets the global Chinese-speaking population with an…

ThursdayJul 27, 2017 9:00 am

Biotech Players Lead the Growth Charge in the Legal Cannabis Market

NetworkNewsWire Editorial Coverage: The backbone of medical advancement is biotechnology, an industry wrought with the incredible potential of novel drug R&D, but vulnerable to the risk of stringent regulatory approval processes. Within this volatile market, however, is the cannabis-biotech sub-sector – a market flourishing with opportunity, innovation, and deep roots of medical possibilities. Fueled by an increasing volume of supportive research, cannabis-based biotech companies are addressing large markets of unmet medical need while rising to meet global demand of epic proportion. Included among several companies in the cannabis-biotech sub-sector is Lexaria Bioscience Corp. (OTCQB: LXRP) (CSE: LXX) (LXRP Profile), a…

WednesdayJul 26, 2017 3:14 pm

Algae Dynamics Corp.’s (ADYNF) Therapeutic Fortified Formulas Likely to Boost Endocannabinoid System

Commercializing proprietary BioSilo® algae cultivation system Developing therapies that combine omega-3s and cannabinoids Poised to enter billion dollar markets If you think you haven’t had cannabinoids because you’ve never used cannabis, you are completely mistaken. You may not have ‘touched’ plant-derived cannabinoids (phytocannabinoids), but it would have been biologically impossible to escape the ones produced by your body (endocannabinoids). Endocannabinoids play an essential mediating role in a number of human physiologic systems. They promote a Goldilocks internal environment, a mean between excess and deficiency in a variety of functions and areas, and recent scholarship has shown that their production is…

Financial news and publishing for public and private companies

Contact us: 512.354.7000